trastuzumab-dkst 150 MG Injection [Ogivri]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

trastuzumab-dkst 150 MG Injection [Ogivri]

150 MG · Injection · injection

A form of trastuzumab-dkst →

trastuzumab-dkst 150 MG Injection [Ogivri] — HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Strength, form, class, interactions & more.

trastuzumab-dkst 150 MG Injection [Ogivri]

Active ingredient

Classification

HER2 (Human Epidermal Growth Factor Receptor 2) inhibitorsHER2/neu Receptor Antagonist

Drug interactions

Trastuzumab-dkst may interact with anthracyclines, leading to an increased risk of cardiac dysfunction.

  • majoranthracyclines — increased risk of cardiac dysfunction
  • moderateanthracyclines — requires close monitoring of cardiac function

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.